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Background: As many as 70% of veterans with chronic pain treated within the US Veterans Administration
(VA) system may have posttraumatic stress disorder (PTSD), and conversely, up to 80% of those with PTSD
may have pain. We describe pain experienced by US service members and veterans with symptoms of PTSD,
and report on the effect of Accelerated Resolution Therapy (ART), a new, brief exposure-based therapy, on
acute pain reduction secondary to treatment of symptoms of PTSD.
Methods: A randomized controlled trial of ART versus an attention control (AC) regimen was conducted
among 45 US service members/veterans with symptoms of combat-related PTSD. Participants received a
mean of 3.7 sessions of ART.
Results: Mean age was 41.0   12.4 years and 20% were female. Most veterans (93%) reported pain. The
majority (78%) used descriptive terms indicative of neuropathic pain, with 29% reporting symptoms of a
concussion or feeling dazed. Mean pre-/post-change on the Pain Outcomes Questionnaire (POQ) was
 16.9916.6 in the ART group versus  0.7914.2 in the AC group (p 0.0006). Among POQ subscales,
treatment effects with ART were reported for pain intensity (effect size  1.81, p 0.006), pain-related
impairment in mobility (effect size  0.69, p 0.01), and negative affect (effect size  1.01, p 0.001).
Conclusions: Veterans with symptoms of combat-related PTSD have a high prevalence of significant pain,
including neuropathic pain. Brief treatment of symptoms of combat-related PTSD among veterans by use of
ART appears to acutely reduce concomitant pain.
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B
y 2013, more than 51,000 individuals in the US
military were wounded in action in the recent
Operation Iraqi Freedom (OIF), Operation Endur-
ing Freedom (OEF), and Operation New Dawn (OND)
conflicts combined (Iraq and Afghanistan Veterans of
America, 2013), and the less visible psychological wounds
of war continue to be a problem (Tanielian & Jaycox,
2008). It is estimated that as many as 70% of veterans
with chronic pain treated within the US Veterans
Administration (VA) system may have posttraumatic
stress disorder (PTSD), and conversely, up to 80% of
those with PTSD may have pain (Beckham et al., 1997;
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et al., 2007; Stecker, Fortney, Owen, McGovern, &
Williams, 2010). Patients with both PTSD and chronic
pain generally present with more complicated clinical
profiles (Sharp & Hanery, 2001), and no formal treatment
guidelines exist for comorbid PTSD and chronic pain
(Muller et al., 2009). Such individuals report much lower
quality of life, and the presence of chronic pain may serve
as a constant reminder of a traumatic event and may also
worsen PTSD symptoms (U.S. Department of Veterans
Affairs, 2007). Further, veterans with PTSD receive more
frequent and higher-dose opioids for pain diagnoses (Seal
et al., 2012). Use of prescription opioids for pain is
associated with risk of alcohol-, drug-, and opioid-related
accidents/overdoses, as well as self-inflicted injuries (Seal,
et al., 2012).
Pain may be categorized by type, including somatic,
visceral, and neuropathic (Fig. 1), and as used in the pre-
sent analysis. Somatic pain is associated with the muscu-
loskeletal tissues, is localized, and is often described as
constant, aching, or pulling. Visceral pain is experienced
in the internal organs, is vague, poorly defined, not locali-
zed, and may be experienced as squeezing or cramping
pain. Neuropathic pain, irrespective of disease condition,
is related to nerve involvement and is often described as
burning, stabbing, or stinging pain, or as pins and needles
(Levy, Chwistek, & Mehta, 2008). Pain is most appro-
priately treated by type and severity.
Musculoskeletal and connective system ailments invol-
ving back, neck, head, and abdominal pain are some
of the most frequent reasons that veterans seek care at
the VA (Gironda, Clark, Massengale, & Walker, 2006;
Haskell et al., 2012; Kang, Mahan, Lee, Magee, & Murphy,
2000; Lew, et al., 2009; Taylor et al., 2012). Evidence-
based therapies serve as separate first-line treatments for
PTSD and pain in veterans, but these therapies are only
partially effective. Therapies used frequently for PTSD
include prolonged exposure (PE) therapy and cognitive
processing therapy (CPT) (U.S. Department of Veterans
Affairs, 2008), both of which are lengthy, costly, and
result in highly variable rates of dropout and treatment
success; cognitive behavioral therapies (CBT) for treat-
ment of pain show mixed results (Basler, Jakle, & Kroner-
Herwig, 1997) and only medium effect sizes (Morley,
Eccleston, & Williams, 1999). Moreover, use of opioid
analgesics by veterans with PTSD requires special atten-
tion because of the potential for addiction and fatal
overdose either by accident or attempted suicide (U.S.
Department of Veterans Affairs, 2009). In addition to
these existing therapies, there is a new approach called
Accelerated Resolution Therapy (ART), an evidence-
based psychotherapy that is delivered in 2 5 sessions
andwithout the need for or use of medications. As part of
a randomized controlled trial (RCT) of the effect of ART
on symptoms of combat-related PTSD (Kip, Rosenzweig,
et al., 2013), the investigators collected data on pain, and,
thus, were able to conduct a secondary analysis that shed
light on the effectiveness of ART for pain management
in service members/veterans with symptoms of PTSD.
While results have indicated statistically and clinically
significant reductions in symptoms of PTSD in US
civilians (Kip et al., 2012; Kip, Sullivan, et al., 2013)
and, more recently, in service members and veterans (Kip,
Rosenzweig, et al., 2013), it was unknown whether ART
would improve pain symptoms. Thus, the purpose of this
paper is to describe the pain experienced by veterans
with symptoms of PTSD and to report the acute effect of
ART on that pain.
Methods
Study design
A two-group RCT was conducted in which consenting
and eligible service members and veterans (described
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Fig. 1. Descriptive terms used to classify origin of reported pain as somatic, visceral, and/or neuropathic among all study
participants.
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an attention control (AC) regimen. Study participants
randomly assigned to AC were offered treatment (cross-
over) with ARTupon completion of the AC regimen. The
Institutional Review Board (IRB) at the University of
South Florida and the DoD Telemedicine and Advanced
Technology Research Center (sponsor of the trial) ap-
proved the trial protocol. All participants provided
written informed consent, and the trial was registered
with ClinicalTrials.gov (NCT01559688).
Recruitment
Participants were recruited from community-based orga-
nizations and veteran membership organizations within
the Tampa Bay area, as well as through academic pro-
grams at the University of South Florida (USF). Re-
ferrals for study participation were provided by the James
A. Haley VA Hospital (Tampa, FL), Bay Pines VA
Hospital (Bay Pines, FL), and United States Special
Operations Command (USSOCOM), Care Coalition,
MacDill Air Force Base (Tampa, FL). Participants
recruited from these sources who received ART and/or
the AC regimens were evaluated and treated at the USF
College of Nursing, Tampa, FL.
Screening
Clinical evaluation used for the parent trial eligibility
consisted of the 17-item PTSD Checklist, Military
Version (PCL-M Checklist), 125-item Psychiatric Diag-
nostic Screening Questionnaire (PDSQ), Brief Mental
Status Exam, and self-developed nine-item ART Intake
Questionnaire. The PCL-M Checklist is a self-report
of DSM-IV symptoms of PTSD in response to stress-
ful military experiences (Blanchard, Jones-Alexander,
Buckley, & Forneris, 1996; Weathers, Litz, Herman,
Huska, & Keane, 1993) and is used with service members
and veterans. The PDSQ was used to screen for Axis
I disorders to serve as a baseline assessment of psycho-
pathology (Zimmerman & Chelminski, 2006; Zimmerman
& Mattia, 2001). The nine-item ART Intake Question-
naire is designed to capture information on traumas
impacting the veterans including the number of traumatic
events, duration of symptoms, self-reported guilt, and
prior treatment. Completion and scoring of the PCL-M
and PDSQ was followed by clinical ARTclinician/veteran
interviews to determine study eligibility.
Trial inclusion criteria were: (1) US service member or
veteran with prior deployment(s); (2) age]18 years; (3)
symptoms of psychological trauma including score ]40
on the PCL-M Checklist and/or endorsement of PTSD
items on the PDSQ; (4) ability to read and speak English
(eighth-grade level) in order to complete survey ques-
tions; (5) denial of suicidal or homicidal ideation; and (6)
no evidence of psychotic behavior or psychological crisis.
Exclusion criteria consisted of: (1) brain injury prohibit-
ing speech, writing, and purposeful actions; (2) major
psychiatric disorder (e.g., bipolar disorder) concomitant
to symptoms of psychological trauma (as defined above);
(3) currently undergoing substance abuse treatment; (4)
previous diagnosis of eye movement disorder sufficient
to interfere with treatment, as anticipated by the ART
clinician; and (5) any medical condition that, in the
judgment of the principal investigator and/or ART
clinician, might place the individual at risk due to a
potential reaction (e.g., previous heart attack, seizure
disorder).
Random assignment
Eligible service members/veterans were randomly as-
signed to the ART or AC regimen in a 1:1 ratio using a
random number generator and variable blocking scheme
(blocks of 4, 6, and 8). The first session (ARTor AC) was
typically scheduled within 1 week (usually sooner) of
screening.
ART intervention
The ART intervention, delivered in 2 5 sessions each
approximately 60 75 min in duration, consisted of two
components and the use of bilateral eye movements. In
the first component, Imaginal Exposure (IE) was used
whereby participants were asked to recall (verbally or
non-verbally) the traumatic event (scene) while focusing
on physiological sensations, thoughts, and emotions.
During this process, the participant, with coaching from
the ART clinician, was composed into a relaxed, alert
state of mind and then exposed to re-activation of the
targeted memory for a short 30 45 s period of time.
This period of exposure to the memory was followed by
identification and diminishment (or eradication) of any
uncomfortable emotional or somatic symptoms.
In the second component, Imagery Rescripting (IR) was
used whereby participants were instructed to visualize
their traumatic scene and imagine changing (replacing)
the imagery and sensory components of the scene to any
positive scene of their choice. As the new positive scene
was then substituted and reviewed, the participant was
asked to try to access the original distressing images.
Treatment of thetraumatic scenewasconsideredcomplete
(successful) when only the replacement scene could be
accessed, although knowledge of the original scene
remained in memory. The number of ART sessions per
patient was variable and was based on processing (treat-
ing) the specific, number of traumatic scenes identified by
the patient as contributing to symptoms of PTSD.
Throughout components and sensation checks of the
therapy, the participant was asked to follow the thera-
pist’s hand back and forth moving the eyes from left to
right, with 40 eye movements per set. During this process,
the participants were not speaking but, rather, ‘‘watch-
ing’’ their original or newly imagined scene. This process
of ‘‘watching’’ the scene (during both IE and IR) while
performing eye movements was repeated multiple times,
ART for treatment of pain
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number required to complete the IE and IR components.
Additional details on the ART protocol have been pub-
lished (Kip, et al., 2012, 2014; Kip, Rosenzweig, et al.,
2013; Kip, Sullivan, et al., 2013).
AC intervention
The AC intervention consisted of two one-hour sessions
of fitness assessment and planning or two one-hour ses-
sions of career assessment and planning, as selected by
the service member/veteran. The fitness assessment and
planning regimen was conducted by a certified health
fitness trainer. The assessment included anthropometric
measures, determination of body fat percentage and body
mass index, review of previous exercise history, and iden-
tification of individualized physical fitness goals. The
career assessment and planning regimen was conducted
by a professional career counselor. It included completion
and review of the Career Planning Scale which encom-
passes six scales covering knowledge of the world of
work, knowledge of occupations, self-knowledge, career
decision-making, career planning, and career implemen-
tation (Liptak, 2001).
Data collection
After screening and enrollment in the trial, participants
completed a demographic and brief medical history
questionnaire. In addition, baseline completion of self-
reported outcome measures (in addition to the previously
completed PCL-M) included the following measures: The
20-item Center for Epidemiologic Studies Depression
Scale (CES-D) (Radloff, 1977); 18-item Brief Symptom
Inventory (BSI) (Derogatis, 2001); 21-item State-Trait
Inventory for Cognitive and Somatic Anxiety (STICSA)
(Ree, French, MacLeod, & Locke, 2008); Pittsburgh
Sleep Quality Index (PSQI) (Buysse, Reynolds, Monk,
Berman, & Kupfer, 1989); 32-item Trauma-Related Guilt
Inventory (TRGI) (Kubany, 1996); 21-item Post-Traumatic
Growth Inventory (PTGI) (Tedeschi & Calhoun, 1996);
26-item Self-Compassion Scale (SCS) (Neff, 2003); 29-
item Aggression Questionnaire (AQ) (Buss & Perry,
1992); and the10-item Alcohol Use Disorder Identifica-
tion Test (AUDIT) (Saunders, Aasland, Babor, de la
Fuente, & Grant, 1993). As part of PTSD comorbidity
evaluation, participants also completed the 20-item Pain
Outcomes Questionnaire (POQ)*Short Form (Clark,
Gironda, & Young, 2003). This reliable and valid instru-
ment contains 19 primary pain items that are rated on an
11-point (0 10) Likert-type scale and one demographic
question. In addition to a total pain score, six subscale
scores can be calculated that correspond to: pain inten-
sity (one item), pain-related impairment in mobility (four
items), pain-related impairment in performing activities
of daily living (four items), sense of impairment in
activity and energy levels (three items), dysphoric affect
and associated symptoms (five items), and pain-related
fear and avoidance (two items). Participants received $50
each time they completed the set of study assessments
(pre-ART, post-ART, and at 3-month follow-up). Despite
having a 3-month posttreatment follow-up, this report
pertains to the acute effect of ARTon pain (i.e., pre-ART
vs. post-ART), since after crossover to ART by the
control group, no randomized comparison was possible
at the 3-month follow-up.
Statistical methods
Demographic, military, and clinical characteristics of
the study sample are described by means and standard
deviations for continuous variables and percentages for
categorical variables. Of the 57 participants randomly
assigned (see Fig. 2), 45 provided pain outcome data
before and after their assigned regimen. Thus, distribu-
tions of baseline characteristics were first compared
between those with and without pain outcome data,
followed by comparisons by random assignment by use
of Student t-tests and Fisher’s exact test. For the study
outcome of change in pain scores on the POQ, analysis of
covariance (ANCOVA) was used to compare mean pre-/
post-differences by random assignment, adjusting for the
baseline value. Standardized effect sizes for pain scores
were calculated as: ([mean before ART - mean after
ART]/standard deviation of treatment difference scores)
(Morris & DeShon, 2002). Pearson correlation coeffi-
cients were calculated to assess the strength of relation-
ship between symptoms of PTSD and pain. Given the
exploratory nature of the analysis, a two-sided p-value of
B0.05 was used to define statistical significance in all
analyses, without adjustment for multiple comparisons.
For total score on the POQ, an intention to treat (ITT)
analysis was conducted assuming no difference (value of
0) in pain scores among the 12 of 57 participants without
complete pain data. Finally, while not defined a priori,
results were examined by two subgroups of interest. This
included: (1) whether the primary trauma for which
treatment was sought was classified as physical (consist-
ing of military sexual trauma, improvised explosive
device blast or combat explosion, or three or more
traumas) versus psychological (consisting of witnessing
of death, execution or major injuries, or homicide of
civilians) and (2) among those with versus without a
history of head trauma.
Results
Sample
A total of 63 service members/veterans were assessed for
trial eligibility, of whom, 57 (90.5%) were eligible and
enrolled (Fig. 2). Of the 57 participants enrolled, 29
(50.9%) were assigned to the ART intervention and 28
(49.1%) were assigned to the AC intervention. A total of
52 of the 57 participants (91.2%) received their assigned
Kevin E. Kip et al.
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regimen. Of these 50 participants, 45 (90%) provided pre-
and post-intervention pain score data, providing the basis
for the analysis. The five participants with missing post-
intervention data did not complete the POQ. Presenting
characteristics were similar between the 45 participants
with and 12 participants without pre- and post-interven-
tion pain outcome data. Apparent exceptions were the 45
participants with pain data being more likely discharged
veterans as opposed to active duty or reservist (75.6% vs.
50.0%, p 0.18), and having received prior treatment for
PTSD (73.3% vs. 50.0%, p 0.17).
Among the 45 participants in the study, the mean age
was 41.0 9 12.4 years, 20% were female, 84.4% were of
Caucasian race, 55.6% had primary military service in
the Army, 44.4% were on disability for PTSD or another
mental health disorder, and 46.7% had lived with trau-
matic memories for more than 10 years. The mean PTSD
symptom score on the PCL-M was 56.9914.9 and mean
total pain score on the POQ was 50.5929.4. Demogra-
phic, military, and clinical characteristics were generally
similar by random assignment (Table 1). Exceptions were
the ART group (compared to AC group) having a higher
prevalence of veterans (non-active duty) (75.6% vs.
50.0%, p 0.03) and Hispanic representation (20.8% vs.
0.0%, p 0.05). Of note, presenting PTSD symptom score
on the PCL-M (p 0.90) and total pain score on the
POQ (p 0.81) were similar by random assignment.
Presenting injuries and pain
As part of the clinician intake and documentation pro-
cess, participants were asked about the kinds of injuries
or problems they were having (i.e., not a self-report
questionnaire). The largest number (29%) reported hav-
ing symptoms of a concussion or feeling dazed, or, simi-
larly, having experienced a traumatic brain injury (TBI)
or head injury (22%) (Table 2). Many reported multiple
problems, and 16% reported tinnitus. Most participants
in the sample (93%) reported pain of some type, and
approximately half (46.7%) reported pain intensity at a
level of four or higher, with some respondents reporting
pain scores as high as 9 on a 0  10 scale. Including all
participants in the sample, the mean pain score was 3.8
(SD  2.6); this mean included the four participants who
reported no pain. When asked to describe the pain they
were experiencing at the clinician intake, the majority
(77.8%) used descriptive terms that would normally
characterize neuropathic pain. This was much higher
than terms used to characterize pain as somatic (26.7%),
visceral (8.9%), or of multiple types (26.7%).
Assessed for eligibility (n=63)
Excluded: (n=6)
Major psychiatric disorder (n=3)
Medical risk (n=2)
Insufficient trauma (n=1)
Analyzed (n=24)
Excluded from analysis (n=2)
Reason: no post treatment pain data
Completed ART intervention (n=26)
Discontinued intervention (n=2)
Decided not to continue (n=1)
Unable to obtain Dr. release (n=1)
Allocated to ART intervention (n=29)
Received allocated intervention (n=28)
Did not receive allocated intervention
(n=1): Reason: work conflict/active duty 
Completed Attention Control regimen (n=24)
Discontinued intervention (n=0)
Allocated to Attention Control group (n=28)
Received allocated intervention (n=24)
Did not receive allocated intervention
Shipped out/active duty (n=2)
Work conflict (n=2)
Analyzed (n=21)
Excluded from analysis (n=3)
Reason: no post treatment pain data
Allocation
Analysis
Follow-Up
Randomized (n=57)
Enrollment
Fig. 2. Consort diagram of the trial population including those screened, enrolled, randomly assigned, completing treatment,
and analyzed.
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The 24 participants assigned to ART who completed
treatment for symptoms of PTSD underwent a mean of
3.791.0 sessions. All 21 participants assigned to the
AC group who initiated the intervention completed two
sessions (per study protocol). Among the 45 completers
of their randomly assigned intervention, the mean pre-/
post-change on the POQ was  16.9916.6 in the ART
group versus  0.7914.2 in the AC group (effect size 
1.04, p 0.0006) (Fig. 3, Table 3). In the ITT analysis
(n 57), the mean pre-/post-change on the POQ was
 14.0916.4 in the ART group versus  0.5912.2 in the
AC group (p 0.0009). Among the POQ subscales, sig-
nificant, acute treatment effects associated with ART
were reported for pain intensity (effect size 1.81,
p 0.006), pain-related impairment in mobility (effect
size 0.69, p 0.01), negative affect (effect size 1.01,
p 0.001), and in a counter-direction, pain-related fear
and avoidance (effect size  0.87, p 0.02). Due to
potential floor effects (i.e., limited pain at baseline),
Table 1. Demographic, military, and clinical characteristics by random assignment
Characteristic AC (n 21) ART (n 24) p
Age in years (mean9SD) 44.0913.5 38.4910.9 0.14
Female gender (%) 19.1 20.8 1.0
Race (%) 0.95
White 85.7 83.3
Black or African American 9.5 12.5
Other 4.8 4.2
Hispanic ethnicity (%) 0.0 20.8 0.05
Current military status (%) 0.18
Active duty 16.7 11.1
Reservist 33.3 13.3
Discharged/veteran 50.0 75.6
Primary branch of military service (%) 0.03
Army 42.9 66.7
Navy 14.3 25.0
Air Force 19.0 8.3
Marines 23.8 0.0
On disability for PTSD/other MH disorder 33.3 54.2 0.23
Five or more traumatic memories currently impacting life (%) 38.1 50.0 0.55
Lived with traumatic memories  10 years (%) 52.4 41.7 0.56
Previous treatment for PTSD (%) 76.2 70.8 0.75
Individual therapy 71.4 58.3 0.53
Group therapy 28.6 20.8 0.73
Pharmacotherapy 52.4 62.5 0.56
PCL-M score (mean9SD) 56.6915.0 57.2915.1 0.90
PCL-M score ]50 (%)
a 57.1 70.8 0.37
PCL-M critical items for PTSD (%)
b 71.4 79.2 0.73
PDSQ score (mean9SD) (T-score) 54.4911.7 54.099.5 0.90
Any PTSD screening criteria (%)
c 85.7 95.8 0.33
POQ scores (mean9SD)
Pain intensity 3.892.9 3.892.3 0.98
Pain-related impairment in mobility 9.2911.4 8.8910.2 0.89
Pain-related impairment in completing ADLs 2.895.9 3.197.4 0.87
Vitality*impairment in activity/energy 14.896.3 15.4912.6 0.76
Negative affect 21.5910.5 20.3910.6 0.70
Pain-related fear and avoidance  0.494.0  1.992.8 0.16
Total POQ score 51.6938.2 49.5929.9 0.81
PDSQ: Psychiatric Diagnostic Screening Questionnaire; PCL-M: PTSD Checklist, Military Version; POQ: Pain Outcomes Questionnaire.
aEstablished screening cutpoint score for probable PTSD.
bDSM-IV symptom criteria for probable PTSD, at least one ‘‘B’’ item (questions
1 5), three ‘‘C’’ items (questions 6 12), and at least two ‘‘D’’ items (questions 13 17) rated as ‘‘Moderate’’ or above.
cScreening criteria for
PTSD from the PCL-M, and/or PDSQ.
Kevin E. Kip et al.
6
(page number not for citation purpose)
Citation: European Journal of Psychotraumatology 2014, 5: 24066 - http://dx.doi.org/10.3402/ejpt.v5.24066analyses were repeated among the 21 participants with a
pain intensity score of 4 or more prior to intervention
(Table 4). In this subset, the mean pre-/post-change on
the POQ was  21.3920.4 in the ART group versus
1.6912.0 in the AC group (effect size  1.32, p 0.004).
In the ART group, there was no discernable pattern of
mean reduction of total POQ scores by the number
of ART sessions received: two (n 3, 22.0924.5); three
(n 7,  7.1913.6); four (n 8,  16.2915.8); and five
(n 6,  26.7914.0).
Subgroup analyses
Among participants with their primary trauma classified
as of physical origin (n 26), the mean pre-/post-change
on the POQ was  19.6917.7 in the ART group versus
 1.3914.9 in the AC group (effect size 1.11, p 0.01).
This compared to  13.2915.0 in the ART group versus
0.1913.9 in the AC group among participants with
primary psychological trauma (n 19, effect size  0.92,
p 0.02). The test for effect modification (interaction)
was not significant (p 0.81). Among participants with-
out a history of head trauma (n 31), the mean pre-/post-
change on the POQ was  15.2919.7 in the ART group
versus  0.7915.6 in the AC group (effect size 0.82,
p 0.01). This compared to  19.899.9 in the ART
group versus  0.899.7 in the AC group among parti-
cipants with a history of head trauma (n 14, effect
size  1.92, p 0.005). Although the effect size asso-
ciated with ART appeared markedly higher among
participants with a history of head trauma, the formal
test for effect modification was not significant (p 0.58).
Relationship between PTSD and pain
At baseline, there was a strong, positive correlation
between symptoms of PTSD measured from the PCL-
M and total pain scores on the POQ (r 0.60, pB0.0001)
(Fig. 4). For the 43 participants who completed treatment
with ART (i.e., irrespective of random assignment), pre-
to post-changes in symptoms of PTSD were positively
associated with changes in pain scores on the POQ
(r 0.33, p 0.03) (Fig. 5).
Discussion
In this RCT designed to evaluate treatment of symptoms
of PTSD, two interesting, and, to some extent, unex-
pected findings were observed. First, the extent and
severity of comorbid pain among US service members/
veterans presenting for treatment of symptoms of PTSD
was substantial. Second, treatment of symptoms of
PTSD with the use of ART appeared to generalize sub-
stantially to meaningful, acute reductions in pain.
Table 2. Frequency and percent of types of injuries and
problems reported by service members and veterans (N 45)
Type of injury or problem Frequency Percent*
Concussion or dazed 13 29
TBI or head injury 10 22
Arm or leg injury or pain 7 16
Ringing in the ears 7 16
Headaches or migraines 4 9
Dizziness or vertigo 3 7
Memory problems 3 7
Other problems: Paraplegia, fibromyalgia,
Meniere’s disease, irritability
49
*Participants reported more than one problem, so totals add up
to more than 100%.
Fig. 3. Plot of change scores on the Pain Outcomes Questionnaire (POQ) before and after treatment with Accelerated
Resolution Therapy (ART) versus before and after an attention control (AC) regimen. Each vertical line represents the response
of an individual service member or veteran. ITT intention to treat analysis.
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Whereas study participants described their injuries or
problems using their own words, there was much simi-
larity in their descriptions. Because of the percent (22%)
reporting TBI or head injury, it is not surprising that
having symptoms of concussion or feeling dazed was the
most common (29%) response. What was not expected
was that the vast majority (93%) of the participants
referred for treatment of symptoms of PTSD also had
pain. Moreover, almost half (47%) reported pain at a
level of 4 or higher on a 0  10 scale. Thus, while sym-
ptoms of PTSD were a significant problem for them and
one for which they were seeking treatment, it was not
their only problem in need of treatment. Many of these
service members/veterans had significant pain that was
intense enough to impair quality of life and possibly
complicate the treatment of symptoms of PTSD.
Unfortunately, health care providers often do not
administer opioid medications in sufficient doses to
relieve pain completely (Broekmans, Vanderschueren,
Morlion, Kumar, & Evers, 2004), and opioids are contra-
indicated in the presence of some comorbidities, includ-
ing acute psychiatric instability and diagnosed substance
use disorder (non-nicotine) not in remission and not in
treatment (US Department of Veterans Affairs, 2010).
In fact, earlier research with veterans found that among
90 veteran inpatients, pain was poorly assessed and
poorly managed (McMillan, Tittle, Hagan, & Laughlin,
2000). Although these service members and veterans in
our sample were experiencing real pain as a result of real
injuries, there is a strong likelihood that their pain was
not being adequately managed because of lack of knowl-
edge about analgesics and fear of opioid-related side
effects on the part of health care providers (Edwards
et al., 2001). Such fear and knowledge deficits have a
negative effect on how analgesics are administered, lead-
ing to mis-managed pain treatment and patient suffering
(Broekmans, et al., 2004). In addition, many health care
providers, because of their poor understanding of opioids
and patients in pain, may label a patient as ‘‘drug-
seeking’’ if he or she seeks analgesics for pain relief
(McCaffery, Grimm, Pasero, Ferrell, & Uman, 2005).
Table 3. Mean pre- to post-assessment differences in POQ scale score by random assignment (all participants)
AC (n 21) ART (n 24) Between group
POQ scale Mean* SD Mean* SD Mean* SD Effect size p**
Pain intensity  0.29 1.59 1.17 1.99 1.45 1.81 0.80 0.006
Mobility  0.45 6.66 3.88 5.94 4.33 6.29 0.69 0.01
ADL  0.05 3.32 1.75 4.72 1.80 4.11 0.44 0.10
Vitality  0.91 4.82 2.79 8.10 3.70 6.74 0.55 0.06
Negative affect 2.18 6.25 9.50 8.10 7.32 7.27 1.01 0.001
Fear 0.55 2.34  2.17 3.67  2.71 3.11  0.87 0.02
Total POQ score 0.71 14.15 16.92 16.62 16.20 15.52 1.04 0.0006
AC: attention control regimen; ART: Accelerated Resolution Therapy intervention; POQ: Pain Outcomes Questionnaire. *Positive values
indicate reductions in POQ scale scores. **Adjusted for baseline value.
Table 4. Mean pre- to post-assessment differences in POQ scale score by random assignment (participants with a pain score of
four or more at study entry)
AC (n 9) ART (n 12) Between group
POQ scale Mean* SD Mean* SD Mean* SD Effect size p**
Pain intensity 0.56 1.13 2.25 1.76 1.69 1.53 1.11 0.08
Mobility  3.00 8.02 7.08 6.71 10.08 7.29 1.38 0.002
ADL  0.56 5.22 3.58 6.22 4.14 5.82 0.71 0.05
Vitality  0.67 4.24 2.58 10.43 3.25 8.40 0.39 0.35
Negative affect 1.56 5.90 7.75 6.97 6.19 6.54 0.95 0.07
Fear 0.56 1.67  1.92 4.27  2.47 3.43  0.72 0.07
Total POQ score  1.56 12.03 21.33 20.36 22.89 17.35 1.32 0.004
AC: attention control regimen; ART: Accelerated Resolution Therapy intervention; POQ: Pain Outcomes Questionnaire. *Positive values
indicate reductions in POQ scale scores. **Adjusted for baseline value.
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The majority of study participants (78%) described their
pain using terms suggestive of neuropathic pain. This
likely relates to the different kinds of physical damage
done by wounds of war, and points out the need for
careful assessment of the types of pain that service
members and veterans experience in order to develop
better treatment protocols. In general, neuropathic pain is
better managed with anti-convulsant or anti-depressant
medications rather than opioids, adding opioids princi-
pally when the veteran is having mixed types of pain.
Wounds that occur in battle might logically be bodily
injury to bones and soft tissue, leading to somatic pain.
However, only 16% of participants reported injuries to
arms and legs, and only 27% used terms that would
normally be used to describe somatic pain. This finding
may be the result of the bias in the way the group was
accrued to the study; that is, all of these US service
members/veterans had symptoms of PTSD and were not
specifically referred because of the type of injury that
they had experienced. The small number of somatic
injuries compared to the much larger number of concus-
sions, feeling dazed, TBI and head injuries probably
accounted for the high prevalence of neuropathic pain
descriptors. The lowest percentage of participants used
the terms that described visceral pain. This is probably
expected in a relatively young population. Visceral pain is
typically seen in angina, kidney colic, or colitis, condi-
tions that are not typically prevalent in young service
members and veterans.
Changes in pain scores
Although pain was not the focus of the original clinical
trial, pain data collected before and after the ART
intervention allowed for this analysis. Thus, the finding
that the service members/veterans in the ART arm of the
trial had significantly greater reduction in pain scores is
quite striking. Pain intensity, which is the score that most
patients and health care providers focus on when asses-
sing for pain, showed a significantly (p 0.006) greater
reduction in the ART group compared to the AC group.
When all subscales of the POQ were summed and
compared, the mean difference between groups was
substantial ( 16.2915.5 points), and highly statistically
significant (p 0.0006), including in the ITT analysis
(p 0.0009). This finding using the total POQ scores
probably occurred because the subscales on the POQ
other than pain intensity all could be affected by mood
states such as PTSD. Thus, when the symptoms of PTSD
improved as a result of ART, the subscales assessing
negative affect and vitality might be expected to improve
as well.
Possible mechanism
An unknown yet signature question from this analysis
centers on the possible mechanism by which ART, an
exposure-based psychotherapy used to treat symptoms of
PTSD, appears to result in favorable concomitant reduc-
tions in pain. Importantly, during the IE phase of the
ART sessions, participants were directed to focus exclu-
sively on physiological sensations elicited from recall
of the traumatic experience. In many instances, recall of
the psychological trauma was directly linked to adverse
pain experiences. Such physiological sensations were
then ‘‘processed out’’ (diminished or eliminated) through
repeated sets of eye movements. Still, how is it that
removing physiological sensations elicited from recall of
previous traumas may conceivably generalize to reduc-
tions in chronic pain at large?
There is evidence that psychological trauma induces
change in biological substrates, which alter both pain
Fig. 4. Scatter plot and linear regression line of the relation-
ship between baseline PTSD symptom score from the PCL-
M and baseline total pain score from the POQ.
Fig. 5. Scatter plot and linear regression line of the relation-
ship between change in PTSD symptom score from the PCL-
M and change in total pain score from the POQ before and
after treatment with Accelerated Resolution Therapy (ART).
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in the brain (Geuze et al., 2007; Liberzon et al., 2007).
However, the manner in which treatment of PTSD
influences such bidirectional relationships is unclear.
Specifically, clinical studies report that pain experience
in persons with PTSD is significantly increased com-
pared with control subjects (Asmundson, Coons, Taylor,
& Katz, 2002; Beckham, et al., 1997; Defrin et al., 2008).
Paradoxically, empirical research also indicates that
patients with PTSD report a decrease in pain intensity
ratings after exposure to traumatic reminders and
temperature-induced pain assessment (Geuze, et al.,
2007; Kraus et al., 2009; Pitman, van der Kolk, Orr,
& Greenberg, 1990). Still, there is limited evidence that
trauma-focused exposure therapy reduces anxiety and phy-
siological arousal, and, in turn, decreases pain severity
and general distress (Dunne, Kenardy, & Sterling, 2012;
Jaspers, 1998; Wald, Taylor, Chiri, & Sica, 2010).
PTSD is characterized by hyperactivation of the
amygdala and hippocampus, and lower activation and
imbalance in the medial prefrontal cortex (Patel, Spreng,
Shin, & Girard, 2012; Vermetten & Bremner, 2002). Of
note, the amygdala integrates nociceptive information
and plays a dual facilitatory and inhibitory role in the
modulation of emotional pain behavior (Neugebauer, Li,
Bird, & Han, 2004). An entirely theoretical hypothesis is
that changing of images and sensations in the imagery
rescripting component of the ART protocol ‘‘corrects’’
disinhibition of the amygdala that is present in PTSD
and, similarly, through the process of reconsolidation
(Monfils, Cowansage, Klann, & LeDoux, 2009), breaks
the direct brain-based association between the trauma
and concomitant pain.
However, our data showed no evidence of ART being
more effective in acutely reducing pain when the principal
trauma being treated included physical injury, as opposed
to being primarily psychological in origin. Thus, an
alternative, more systemic hypothesis is that improvement
of PTSD symptoms with ART, especially reduction in
sleep disturbance which is exceptionally prevalent in
PTSD patients (Maher, Rego, & Asnis, 2006), may result
in the secondary benefits of normalized immune function
and reduced somatization, and, therefore, reduced pain
(Gupta, 2013). Clearly, future neuroimaging studies are
required to elucidate how exposure-based therapies,
including ART, may generalize to concomitant reduction
in pain.
Strengths and limitations
Strengths of the study include the use of a highly
standardized treatment protocol (ART), a wide range of
therapists with different backgrounds to enhance the
generalizability of treatment delivery, and the exclusion of
involvement by the founder or lead ART trainer with any
outcome assessment, to eliminate potential ascertainment
bias. A principal limitation is that the ART intervention
was not designed (or delivered) specifically for pain
reduction concomitant to symptoms of PTSD. Thus,
theoretical explanations for our results range from a
possible spurious association (i.e., no true effect of ART
on pain reduction) to a potential underestimation of the
effect of ARTon pain reduction (i.e., had the intervention
been tailored and delivered specifically for pain). In
addition, the ART intervention was not compared to
an active psychotherapy or otherwise pain reduction
regimen. Thus, no direct comparison of treatment effi-
cacy of ART versus current first-line treatments for pain
management can be made. By design, the AC group was
not parallel in contact hours to the ART intervention.
Although not methodologically ideal, the AC group
showed essentially no reduction in overall pain, a finding
we believe would have likely continued had additional
control sessions been offered. However, random assign-
ment was unblinded; hence, the potential existed for
over-reporting of reductions in pain with the ART inter-
vention. In addition, formal diagnoses of PTSD were not
used; hence, results pertain to symptoms of PTSD and
pain, and not diagnostic criteria. The study was con-
ducted primarily among males and among those not in a
psychological crisis, which limits broad generalizability.
Finally, the present analysis is based on the acute effect
of ART on pain reduction secondary to treatment of
symptoms of PTSD. Long-term sustainability of results
cannot be concluded from this analysis.
Conclusions
This first controlled trial of ART for treatment of
symptoms of combat-related PTSD substantiates a high
prevalence of significant pain in US service members and
veterans, including that of neuropathic origin, frequent
head trauma, symptoms of concussion, or feeling dazed.
Moreover, this analysis indicates that brief treatment
with ART for symptoms of combat-related PTSD among
service members/veterans also appears to have a marked
generalizing effect to reductions in concomitant pain.
Tailoring and future study of ART specific to pain
management in service members and veterans appears
warranted, as does mechanistic studies designed to iden-
tify how components of the ART protocol may reduce
pain symptoms in conjunction with treatment of symp-
toms of combat-related PTSD.
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